HomeFUNDING

Category: FUNDING

Medical device and diagnostics companies are always looking for ways to improve their products and services. In the ever-changing landscape of the healthcare industry, it’s essential for these companies to stay ahead of the curve. That’s why funding is always news.

Series A, B, and other rounds of funding are essential for medical device and diagnostics companies. They provide the necessary capital to help these businesses grow and innovate. And with so many investors interested in this space, there are plenty of opportunities for companies to secure the funding they need.

AISAP Raises $13 Million in...

May 2, 2024

"Obtaining an accurate ultrasound diagnosis in time can literally be the difference between life and death, so the fact that so many patients are forced to wait up to a month for one is nothing short of a global health crisis," says AISAP CEO Roni Attali. "This problem is particularly acute in rural areas or those with fewer resources, and therefore disproportionately impacts disadvantaged populations."

Vitestro Secures $22 Million (€20...

April 30, 2024

Co-led by return investor Sonder Capital and new investor NYBC Ventures, with participation from Invest-NL, the European Innovation Council Fund (EIC Fund), and existing private investors, the oversubscribed funding round will support Vitestro’s commercialization in Europe and its organizational expansion into the U.S. market.

AISAP Raises $13 Million in Seed Funding for First AI-Powered, Point Of Care Ultrasound Diagnostic Solution

May 2, 2024

Ensysce Biosciences Secures $60 Million Capital Commitment From Global Emerging Markets

Ensyce Biosciences notes under the accord, GEM agrees to provide Ensysce with a share subscription facility of up to $60 million for a 36-month term following the public listing of the Company's common stock.

December 31, 2020

AIVITA Biomedical Successfully Closes $25 Million Financing Round: Funds Support Ongoing Development of Personalized COVID-19 Prevention Vaccine

The roceeds will support clinical development of AIVITA's personalized immunotherapy programs.

December 29, 2020

Coagulo Medical Technologies Raises $6.5 Million in Financing: To Accelerate Delivery of Disruptive Coagulation Diagnostics Platform

The company also announced that it has been awarded a Small Business Innovation Research (SBIR) grant by the National Science Foundation to accelerate delivery of breakthrough innovations amid the global COVID–19 public health crisis, which has called attention to the limitations of conventional coagulation tests.

December 23, 2020

Atriomx Health Announces $10 Million Series A Financing-Funds to Be Used for Development and Clinical Study

"This financing will allow Atriomx to pursue the tremendous opportunity to transform the diagnosis and treatment of atrial fibrillation stemming from the application of novel AF detection and characterization capabilities to data that can be collected non-invasively," said Duke Rohlen, CEO of Ajax Health and Zeus Health.

December 22, 2020

Heru Completes FDA Registration Following a $2.7M Seed Round: Expands Leadership Team

The funding facilitates the completion of current clinical trials for FDA clearance of Heru’s wearable AI platform and subsequent commercialization efforts.

December 21, 2020

Peptilogics Closes $35.4 Million Series B Financing

The proceeds of the financing will be used to expand Peptilogics' computational platform and invest in technologies to improve its drug design engine, as well as accelerate the development of a pipeline of peptide therapeutics

December 21, 2020

Ingenion Medical Wins Innovate £100,000 UK Grant – Funds to Be Used to Gain a CE Mark for Its CymActive™ Urinary Catheter

December 18, 2020 Ingenion Medical today, announces it has been awarded nearly £100,000 in grant funding from Innovate UK, the country’s innovation agency. Ingenion Medical will use the proceeds over the next six months to gain a CE Mark for its CymActive™ urinary catheter, a novel medical device to treat male patients suffering from chronic urinary retention. Ingenion’s CEO Edward Cappabianca said, “Our technology’s proprietary, a patent-pending magnetic valve lets patients control their urination, without surgery or drugs.” The device, designed to work with...

December 18, 2020

Rhia Ventures Invests in OCON Healthcare’s Ballerine – the 1st & Only 3D Sperical Copper IUB

Rhia Ventures notes the financing will also help expand Phase II clinical trials for OCON's SEADTM product, which offers point-of-care therapy for abnormal uterine bleeding.

December 18, 2020

Verily Announces $700 Million Investment Round from Current Investors: Funds to Support Rapid Commercial Expansion

Verily current investors, include Alphabet, Silver Lake, Temasek, Ontario Teachers’ Pension Plan and others.

December 17, 2020